Skip to main content
. 2024 Aug 1;5(8):101663. doi: 10.1016/j.xcrm.2024.101663

Figure 7.

Figure 7

Clinical evidence of the occurrence of lipid peroxidation at disease progression following D/T treatment

Representative 4-HNE immunostaining in patient samples pre- and post-D/T treatment. Immunostaining for the epithelial marker CK7 was performed in consecutive sections as control. Scale bars represent 75 μm.